These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9260237)

  • 1. A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome.
    Broyer M; Terzi F; Lehnert A; Gagnadoux MF; Guest G; Niaudet P
    Pediatr Nephrol; 1997 Aug; 11(4):418-22. PubMed ID: 9260237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
    Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
    Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis.
    Rizzato G; Riboldi A; Imbimbo B; Torresin A; Milani S
    Respir Med; 1997 Sep; 91(8):449-60. PubMed ID: 9338047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent effects of deflazacort and prednisone on growth and skeletal maturation.
    Aicardi G; Benso L; Vignolo M; Terragna A; Verrina E; Cordone G; Coppo R; Sernia O; Sardella ML; Di Battista E
    Br J Rheumatol; 1993 May; 32 Suppl 2():39-43. PubMed ID: 8495279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with deflazacort in children and adolescents after renal transplantation.
    Schärer K; Feneberg R; Klaus G; Paschen C; Wüster C; Mehls O; Schaefer F
    Pediatr Nephrol; 2000 Jun; 14(6):457-63. PubMed ID: 10872183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis.
    Aicardi G; Milani S; Imbimbo B; Vignolo M; Di Battista E; Gusmano R; Terragna A; Cordone G; Cottafava F; Coppo R
    Calcif Tissue Int; 1991 Apr; 48(4):283-7. PubMed ID: 2059880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head to head comparison of adverse effects and efficacy between high dose deflazacort and high dose prednisolone in systemic lupus erythematosus: a prospective cohort study.
    Ganapati A; Ravindran R; David T; Yadav B; Jeyaseelan V; Jeyaseelan L; Danda D
    Lupus; 2018 May; 27(6):890-898. PubMed ID: 29320974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
    Griggs RC; Miller JP; Greenberg CR; Fehlings DL; Pestronk A; Mendell JR; Moxley RT; King W; Kissel JT; Cwik V; Vanasse M; Florence JM; Pandya S; Dubow JS; Meyer JM
    Neurology; 2016 Nov; 87(20):2123-2131. PubMed ID: 27566742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deflazacort induced stronger immunosuppression than expected.
    Gonzalez-Castañeda RE; Castellanos-Alvarado EA; Flores-Marquez MR; Gonzalez-Perez O; Luquin S; Garcia-Estrada J; Ramos-Remus C
    Clin Rheumatol; 2007 Jun; 26(6):935-40. PubMed ID: 16738843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases.
    Scudeletti M; Puppo F; Lanza L; Mantovani L; Bosco O; Iudice A; Imbimbo B; Indiveri F
    Eur J Clin Pharmacol; 1993; 45 Suppl 1():S29-34. PubMed ID: 8313931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deflazacort in juvenile chronic arthritis.
    Loftus JK; Reeve J; Hesp R; David J; Ansell BM; Woo PM
    J Rheumatol Suppl; 1993 Apr; 37():40-2. PubMed ID: 8501751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency ratio--a brief synopsis.
    Avioli LV
    Br J Rheumatol; 1993 May; 32 Suppl 2():24-6. PubMed ID: 8495276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
    Loftus J; Allen R; Hesp R; David J; Reid DM; Wright DJ; Green JR; Reeve J; Ansell BM; Woo PM
    Pediatrics; 1991 Sep; 88(3):428-36. PubMed ID: 1881719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deflazacort for the treatment of Duchenne Dystrophy: a systematic review.
    Campbell C; Jacob P
    BMC Neurol; 2003 Sep; 3():7. PubMed ID: 12962544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deflazacort in the treatment of haematologic disorders.
    Gobbi M; Scudeletti M
    Eur J Clin Pharmacol; 1993; 45 Suppl 1():S25-8. PubMed ID: 8313930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of lymphocyte subpopulations in chronic autoimmune inflammatory rheumatic diseases. II. Polymyalgia rheumatica: behaviour of lymphocyte subpopulations during treatment with two different corticosteroids].
    Coaccioli S; Pinoca F; Giuliani M; Sabatini C; Puxeddu A
    Minerva Med; 2005 Oct; 96(5):379-87. PubMed ID: 16227953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study.
    Saviola G; Abdi Ali L; Shams Eddin S; Coppini A; Cavalieri F; Campostrini L; Sacco S; Bucci M; Cirino G; Rossini M
    Rheumatology (Oxford); 2007 Jun; 46(6):994-8. PubMed ID: 17384176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro improvement of chlorambucil-induced cytotoxicity by deflazacort and 6-methylprednisolone in B-cell chronic lymphocytic leukaemia.
    Morabito F; Callea I; Irrera G; Cartisano G; Dattola A; Rodinò A; Brugiatelli M
    Eur J Haematol; 1997 May; 58(5):301-6. PubMed ID: 9222284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deflazacort in comparison to other steroids for nephrotic syndrome.
    Jat KR; Khairwa A
    Indian J Nephrol; 2012 Jul; 22(4):239-45. PubMed ID: 23162265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on strategies for improving growth and body composition after renal transplantation.
    Ferraris JR; Pasqualini T; Alonso G; Legal S; Sorroche P; Galich A; Coccia P; Ghezzi L; Ferraris V; Karabatas L; Guida C; Jasper H
    Pediatr Nephrol; 2010 Apr; 25(4):753-62. PubMed ID: 20151158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.